{
    "clinical_study": {
        "@rank": "38440", 
        "arm_group": {
            "arm_group_label": "1", 
            "description": "Korean adults aged 50 years and older who receive Prevenar13\u2122 in a routine clinical setting"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to assess safety profile of Prevenar 13\u2122 when used among Korean\n      adults in the routine clinical setting, as required for any new drug approved by Korea Food\n      and Drug Administration (KFDA)."
        }, 
        "brief_title": "Post Market Surveillance to Observe Safety of Prevenar13\u2122 in Adults", 
        "completion_date": {
            "#text": "May 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Pneumococcal Disease", 
        "detailed_description": {
            "textblock": "non-randomization, non-probability sampling"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Korean adults aged 50 years and older; provided the conditions pertaining to\n             contraindications, warnings, precautions, and interactions stated in the local\n             product document do not apply.\n\n          -  Evidence of a personally signed and dated informed consent document indicating that\n             the subject(or a legally acceptable representative) has been informed of all\n             pertinent aspects of the study.\n\n        Exclusion Criteria:\n\n          -  Subjects who are not indicated and/or contraindicated for the Prevenar13 usage will\n             not be included."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "50 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Korean adults aged 50 years and older who receive Prevenar13\u2122 in a routine clinical\n        setting"
            }
        }, 
        "enrollment": {
            "#text": "600", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01834222", 
            "org_study_id": "B1851143"
        }, 
        "intervention": {
            "arm_group_label": "1", 
            "description": "Non-intervention", 
            "intervention_name": "Non-intervention", 
            "intervention_type": "Biological", 
            "other_name": "Non-intervention"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "February 20, 2014", 
        "link": {
            "description": "To obtain contact information for a study center near you, click here.", 
            "url": "https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=B1851143&StudyName=Post%20Market%20Surveillance%20to%20Observe%20Safety%20of%20Prevenar13%u2122%20in%20Adults"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "GwangJu", 
                        "country": "Korea, Republic of", 
                        "zip": "501-190"
                    }, 
                    "name": "Dr. Lee's Medical Clinic"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gyeonggi-do", 
                        "country": "Korea, Republic of", 
                        "zip": "463-823"
                    }, 
                    "name": "Bundang 21st Clinic"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_groups": "1", 
        "official_title": "Post Marketing Surveillance to Observe Safety of Prevenar 13 in Adults", 
        "overall_contact": {
            "last_name": "Pfizer CT.gov Call Center", 
            "phone": "1-800-718-1021"
        }, 
        "overall_official": {
            "affiliation": "Pfizer", 
            "last_name": "Pfizer CT.gov Call Center", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Safety profile following administration of Prevenar13- Clinical nature, frequency, duration, severity of adverse events; discontinuation due to adverse events; outcome and possible causality", 
            "safety_issue": "Yes", 
            "time_frame": "28 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01834222"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Pfizer", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pfizer", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2014"
    }
}